New Biologic STELARA(TM) Receives Approval in Europe for Treatment of Moderate to Severe Plaque Psoriasis
Beerse, Belgium (ots/PRNewswire) - - First and Only Biologic Approved With Infrequent, Every Twelve-Week Maintenance Dosing BEERSE, Belgium, January 22 /PRNewswire/ -- Janssen-Cilag announced today that STELARA(TM) (ustekinumab), the first in a new class of biologics, has been approved by the ...